{"id":"https://openalex.org/W2024925968","doi":"https://doi.org/10.1007/bf00422808","title":"The facilitation of discrimination performance by physostigmine sulphate","display_name":"The facilitation of discrimination performance by physostigmine sulphate","alternate_titles":[],"publication_year":1972,"publication_date":"1972-01-01","ids":{"openalex":"https://openalex.org/W2024925968","doi":"https://doi.org/10.1007/bf00422808","mag":"2024925968","pmid":"https://pubmed.ncbi.nlm.nih.gov/4642467"},"language":"en","primary_location":{"id":"doi:10.1007/bf00422808","doi":"https://doi.org/10.1007/bf00422808","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00422808","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacologia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2024925968"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113530020","display_name":"David M. Warburton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71052956","display_name":"University of Reading","ror":"https://ror.org/05v62cm79","country_code":"GB","type":"education","lineage":["https://openalex.org/I71052956"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. M. Warburton","raw_affiliation_strings":["Reading University, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Reading University, England","institution_ids":["https://openalex.org/I71052956"]}]},{"author_position":"last","author":{"id":null,"display_name":"K. Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K. Brown","raw_affiliation_strings":["Queen's University, Belfast","Queen\u2019s University Belfast#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen's University, Belfast","institution_ids":["https://openalex.org/I126231945"]},{"raw_affiliation_string":"Queen\u2019s University Belfast#TAB#","institution_ids":["https://openalex.org/I126231945"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":3.9433,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.92736842,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"27","issue":"3","first_page":"275","last_page":"284"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brightness-discrimination","display_name":"brightness discrimination","score":0.7160000205039978},{"id":"https://openalex.org/keywords/attention","display_name":"attention","score":0.6660000085830688},{"id":"https://openalex.org/keywords/cholinesterase-inhibition","display_name":"cholinesterase inhibition","score":0.8019999861717224},{"id":"https://openalex.org/keywords/scopolamine-hydrobromide","display_name":"scopolamine hydrobromide","score":0.8180000185966492},{"id":"https://openalex.org/keywords/signal-detection-analysis","display_name":"signal detection analysis","score":0.7229999899864197},{"id":"https://openalex.org/keywords/stimulus-sensitivity","display_name":"stimulus sensitivity","score":0.746999979019165},{"id":"https://openalex.org/keywords/response-bias","display_name":"response bias","score":0.871999979019165},{"id":"https://openalex.org/keywords/response-inhibition","display_name":"response inhibition","score":0.6110000014305115},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.3190000057220459}],"concepts":[{"id":"https://openalex.org/C2776663719","wikidata":"https://www.wikidata.org/wiki/Q410595","display_name":"Physostigmine","level":3,"score":0.9614828824996948},{"id":"https://openalex.org/C1337776","wikidata":"https://www.wikidata.org/wiki/Q1941955","display_name":"Facilitation","level":2,"score":0.7122746109962463},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.6202231645584106},{"id":"https://openalex.org/C2779918689","wikidata":"https://www.wikidata.org/wiki/Q3771842","display_name":"Stimulus (psychology)","level":2,"score":0.5175094604492188},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.5026824474334717},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44944196939468384},{"id":"https://openalex.org/C2909050532","wikidata":"https://www.wikidata.org/wiki/Q337188","display_name":"Scopolamine Hydrobromide","level":4,"score":0.4391654431819916},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4301702678203583},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39394569396972656},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3217165470123291},{"id":"https://openalex.org/C2775910092","wikidata":"https://www.wikidata.org/wiki/Q180623","display_name":"Acetylcholine","level":2,"score":0.31119459867477417},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2783169746398926},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2612912058830261},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.20057892799377441},{"id":"https://openalex.org/C33789571","wikidata":"https://www.wikidata.org/wiki/Q410959","display_name":"Muscarinic acetylcholine receptor","level":3,"score":0.1754867136478424},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001288","descriptor_name":"Attention","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D002802","descriptor_name":"Cholinesterases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004192","descriptor_name":"Discrimination, Psychological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010830","descriptor_name":"Physostigmine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012601","descriptor_name":"Scopolamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/bf00422808","doi":"https://doi.org/10.1007/bf00422808","is_oa":false,"landing_page_url":"https://doi.org/10.1007/bf00422808","pdf_url":null,"source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacologia","raw_type":"journal-article"},{"id":"pmid:4642467","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4642467","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacologia","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W386731869","https://openalex.org/W1968071238","https://openalex.org/W1971048984","https://openalex.org/W1978952872","https://openalex.org/W1979982202","https://openalex.org/W1982006712","https://openalex.org/W1995899276","https://openalex.org/W2025856505","https://openalex.org/W2026681455","https://openalex.org/W2031050189","https://openalex.org/W2031760775","https://openalex.org/W2033383481","https://openalex.org/W2033444952","https://openalex.org/W2043242972","https://openalex.org/W2082738197","https://openalex.org/W2093237151","https://openalex.org/W2150358327","https://openalex.org/W2270783639","https://openalex.org/W2331131332","https://openalex.org/W2398771017","https://openalex.org/W4246324511","https://openalex.org/W4248694980"],"related_works":["https://openalex.org/W2017045974","https://openalex.org/W2031186110","https://openalex.org/W1978952872","https://openalex.org/W2049448697","https://openalex.org/W2094130562","https://openalex.org/W2078273531","https://openalex.org/W2090032446","https://openalex.org/W2018970026","https://openalex.org/W2428814968","https://openalex.org/W1923321596"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2024925968","counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
